Bartlett R H, Gazzaniga A B, Jefferies M R, Huxtable R F, Haiduc N J, Fong S W
Trans Am Soc Artif Intern Organs. 1976;22:80-93.
We have used prolonged extracorporeal membrane oxygenation (ECMO) in the treatment of 13 moribund infants (including 9 neonates), with 4 survivors (3 neonates). Successfully treated cases include post-operative cardiac failure, infant respiratory distress syndrome, massive meconium aspiration, and persistent fetal circulation. All cases have been managed with veno-arterial bypass at flow rates of 80-100 cc/Kg/min. Carotid cannulation for arterial access and careful control of heparin anticoagulation based on whole blood activated clotting time are among the techniques which have contributed to this success. Progressive pulmonary or cardiac failure has been the major problem in older infants, intracranial bleeding is the major problem in neonates. Both of these problems could be minimized by instituting ECMO earlier in the clinical course, but this awaits development of reliable early predictors of mortality.
我们采用延长体外膜肺氧合(ECMO)治疗了13例濒死婴儿(包括9例新生儿),4例存活(3例新生儿)。成功治疗的病例包括术后心力衰竭、婴儿呼吸窘迫综合征、大量胎粪吸入和持续性胎儿循环。所有病例均采用静脉-动脉旁路,流速为80-100 cc/(kg·min)。颈动脉插管用于动脉通路,并根据全血活化凝血时间仔细控制肝素抗凝,这些技术都促成了这一成功。进行性肺或心力衰竭是大龄婴儿的主要问题,颅内出血是新生儿的主要问题。通过在临床过程中更早地实施ECMO,这两个问题都可以得到最小化,但这有待可靠的早期死亡率预测指标的开发。